• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Successful treatment of interstitial pneumonia with lipo-PGE1 and pentoxifylline in a patient with dermatomyositis].

作者信息

Asanuma Y, Yamada H, Matsuda T, Hoshi K, Ichikawa Y, Mizushima Y, Niimi H

机构信息

Department of Internal Medicine and Laboratory Medicine, Saint Marianna University School of Medicine, Kawasaki-city, Kanagawa.

出版信息

Ryumachi. 1997 Oct;37(5):719-26.

PMID:9396376
Abstract

Interstitial pneumonia complicated with dermatomyositis sometimes shows a resistance to high dose steroid therapy and a fatal course particularly in patients without showing the elevation of creatine kinase. We experienced a 48 year old woman who developed heliotrope rash, Gottron's sign, multiple cutaneous ulcers, and dyspnea on exertion. These symptoms were resistant to low dose steroid therapy. Serum levels of creatine kinase were normal. Anti-nuclear antibodies and anti-Jo-1 antibody were negative. High resolution CT scan of the chest showed areas of multiple air space consolidation and subpleural linear shadows. Lung biopsy performed under video-assist thoracosurgery revealed diffuse alveolitis with scattered lymphoid folicules and mild accumulation of macrophages in the alveolar spaces. There were no honey-combing. These features were compatible with "non-specific interstitial penumonia" proposed by Katzenstein, 1995. The patient was treated with 10 micrograms lipo-PGE1, PGE1 incorporated in lipid microspheres, and 300 mg pentoxifylline, which resulted in a dramatic improvement of both interstitial pneumonia and cutaneous ulcers. The present case suggested a novel strategy for the treatment of interstitial pneumonia.

摘要

相似文献

1
[Successful treatment of interstitial pneumonia with lipo-PGE1 and pentoxifylline in a patient with dermatomyositis].
Ryumachi. 1997 Oct;37(5):719-26.
2
[A case of amyopathic dermatomyositis associated with interstitial pneumonitis].[1例伴间质性肺炎的无肌病性皮肌炎]
Ryumachi. 1997 Oct;37(5):714-8.
3
[A case of corticosteroid-resistant nonspecific interstitial pneumonia associated with dermatomyositis successfully treated with cyclosporin A].[一例与皮肌炎相关的对皮质类固醇耐药的非特异性间质性肺炎经环孢素A成功治疗的病例]
Nihon Kokyuki Gakkai Zasshi. 2005 Mar;43(3):171-8.
4
[A case of amyopathic dermatomyositis with interstitial pneumonia: successful treatment with a combination of prednisolone and cyclosporin A].[一例伴间质性肺炎的无肌病性皮肌炎:泼尼松龙与环孢素A联合治疗成功]
Nihon Kokyuki Gakkai Zasshi. 2004 May;42(5):429-34.
5
[Interstitial pneumonia complicating amyopathic dermatomyositis: a case report].[间质性肺炎并发无肌病性皮肌炎:一例报告]
Rev Pneumol Clin. 2009 Dec;65(6):353-6. doi: 10.1016/j.pneumo.2009.05.004. Epub 2009 Oct 21.
6
[A case of nonspecific interstitial pneumonia associated with amyopathic dermatomyositis efficiently treated with a combination of cyclosporin A and prednisolone].[1例无肌病性皮肌炎相关的非特异性间质性肺炎经环孢素A和泼尼松龙联合治疗有效]
Nihon Kokyuki Gakkai Zasshi. 2002 Jun;40(6):478-83.
7
[Effective treatment of interstitial pneumonia with tacrolimus in a patient with dermatomyositis who was intolerant to cyclosporin-A].他克莫司有效治疗对环孢素 A 不耐受的皮肌炎患者的间质性肺炎
Nihon Kokyuki Gakkai Zasshi. 2010 Jun;48(6):444-8.
8
[A case of amyopathic dermatomyositis with rapidly progressive interstitial pneumonia].[一例伴快速进展性间质性肺炎的无肌病性皮肌炎病例]
Ryumachi. 2000 Aug;40(4):705-10.
9
[Clinicopathological features of interstitial pneumonia associated with amyopathic dermatomyositis].[无肌病性皮肌炎相关间质性肺炎的临床病理特征]
Nihon Kyobu Shikkan Gakkai Zasshi. 1997 Mar;35(3):281-7.
10
[A case of dermatomyositis which rapidly developed to respiratory failure in the presence of pneumomediastinum].[一例皮肌炎在存在纵隔气肿的情况下迅速发展为呼吸衰竭的病例]
Nihon Kyobu Shikkan Gakkai Zasshi. 1989 Jul;27(7):848-54.